Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Allows Sartorius to transparently source renewable, certified raw materials for the production of plastic components.
March 31, 2025
By: Charlie Sternberg
Sartorius has earned its first certificates from the International Sustainability and Carbon Certification (ISCC) for its production sites in Aubagne, France, and Stonehouse, UK. The ISCC Plus certification allows Sartorius to transparently source renewable, certified raw materials for the production of plastic components, significantly reducing the proportion of fossil-based materials. Further plants in Germany and Finland are to follow.
At its certified sites, Sartorius produces Ambr bioreactor vessels, Vivaflow filters, and selected Flexsafe bags for the manufacture of biopharmaceuticals. ISCC’s transparent accounting system allows for the integration of renewable and recycled feedstock—such as recycled plastic—into existing processes, with usage tracked and documented across the entire value chain. In the three product lines, ISCC Plus-certified materials now cut the share of fossil-based compounds by an average of 50 percent.
“By using renewable materials, we are actively reducing fossil raw materials in our products, offering sustainable alternatives that our customers can easily adopt,” said René Fáber, Head of the Bioprocess Division and Member of the Executive Board at Sartorius. “For years, our technologies have helped customers to replace energy-, water- and chemical-intensive manufacturing processes for biopharmaceuticals with more resource-efficient single-use options, thereby reducing their environmental footprint. The ISCC Plus certification reinforces our ongoing commitment to advancing more sustainable practices.”
In addition to supporting its customers’ sustainability efforts, Sartorius aims to further reduce its own ecological footprint and pursue significant climate ambitions: By 2045, Sartorius intends to fully decarbonize its business activities, achieve net-zero CO2 emissions and thus become climate neutral. By 2030, 100 percent of the electricity purchased worldwide should come from renewable sources.
In January, Sartorius and McMaster University opened a new bioprocessing automation lab at the university’s Faculty of Engineering in Hamilton, Ontario.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !